Page last updated: 2024-10-21

acebutolol and Amentia

acebutolol has been researched along with Amentia in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zagórska, A1
Bucki, A1
Partyka, A1
Jastrzębska-Więsek, M1
Siwek, A1
Głuch-Lutwin, M1
Mordyl, B1
Jaromin, A1
Walczak, M1
Wesołowska, A1
Kołaczkowski, M1

Other Studies

1 other study available for acebutolol and Amentia

ArticleYear
Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia.
    European journal of medicinal chemistry, 2022, Apr-05, Volume: 233

    Topics: Animals; Antipsychotic Agents; Dementia; Humans; Ligands; Mice; Phosphoric Diester Hydrolases; Serot

2022